A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF Application WO-2024052336-A1 World Intellectual Property Organisation (WIPO) 14 Mar 2024
MVA-BASED VECTORS AND THEIR USE AS VACCINE AGAINST SARS-COV-2 Application EP-4316514-A1 European Patent Office 07 Feb 2024
INTRANASAL FORMULATIONS AND ANTI-SARS-COV-2-SPIKE PROTEIN ANTIBODIES Application WO-2023155902-A1 World Intellectual Property Organisation (WIPO) 24 Aug 2023
EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3… Application WO-2023091988-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
Anti-spike glycoprotein antibodies and the therapeutic use thereof Grant US-11623949-B2 United States of America 11 Apr 2023
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2… Grant US-11498944-B2 United States of America 15 Nov 2022
ANTI-SARS-COV-2 SPIKE GLYCOPROTEIN ANTIBODIES AND THE THERAPEUTIC USE THEREOF Application WO-2022165039-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2022
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2… Grant US-11384122-B2 United States of America 12 Jul 2022
SINGLE DOMAIN ANTIBODIES THAT TARGET SARS-COV-2 Application WO-2022053839-A1 World Intellectual Property Organisation (WIPO) 17 Mar 2022
MULTISPECIFIC CORONAVIRUS ANTIBODIES Application WO-2022006562-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022
CORONAVIRUS VACCINES Application WO-2021170869-A1 World Intellectual Property Organisation (WIPO) 02 Sep 2021